Pulmonary uptake of Tc-99m MIBI in a patient with progressive systemic sclerosis (PSS, diffuse scleroderma) is described. Nonspecific alveolitis, active interstitial fibrosis pulmonary hypertension, and specific uptake by the fibroblasts in patients with PSS are possible mechanisms of Tc-99 MIBI uptake observed.